Medicines Patent Pool
Non-Profit & Charitable Organizations · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Chemin Louis Dunant 17, Geneva, Geneva, ...Phone Number
+41 225335050Website
www.medicinespatentpool.orgRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Medicines Patent Pool
The Medicines Patent Pool (MPP) is a UN-backed international public health organization focused on increasing access to essential medicines and health technologies in low- and middle-income countries. MPP collaborates with partners to license these medicines and technologies, promoting the development of new formulations and expanding generic manufacturing markets. The organization addresses critical health issues, including HIV, hepatitis, tuberculosis, and non-communicable diseases, aiming to make affordable treatments available to those in need. Through its innovative business model, MPP plays a vital role in enhancing global health and ensuring universal access to life-saving medicines.Explore more
Medicines Patent Pool Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medicines Patent Pool your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Medicines Patent Pool
Medicines Patent Pool, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Medicines Patent Pool recently announced quarterly report
Check if Medicines Patent Pool has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Medicines Patent Pool has new funding data
Click to see if Medicines Patent Pool had a recent Job posting/layoffs
Product Launch: Get notified when Medicines Patent Pool launches new products
Check out if Medicines Patent Pool is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Medicines Patent Pool
Find more new buyers
Company Profile Activity
Activity Insights
Medicines Patent Pool is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Medicines Patent Pool is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Medicines Patent Pool.
Medicines Patent Pool Tech Stack
A closer look at the technologies used by Medicines Patent Pool
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Sales, Logistics / Supply Chain, Machinery, Sustainability, Field /Outside Sales, Field Marketing, Manufacturing Operations, Operations
Event
Events
Event
will be attending the The Battery Show and Electric & Hybrid Vehicle Technology Conference North America 2023 conference as an exhibitor. The event will occur from September 12 to September 14, 2023.
Events
Event
will be attending the CONEXPO-CON/AGG 2023 conference as an exhibitor. The event will occur from March 14 to March 19, 2023.
Project
Product Management
Medicines Patent Pool News & Media
The Medicines Patent Pool (MPP) signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia
This is the first ever public health-oriented voluntary licence agreement on a cancer medicine GENEVA, Oct. 20, 2022 /PRNewswire/ -- On the side lines of the World Cancer Congress, the Medicines Patent Pool (MPP) today announced the signing of a voluntary licensing agreement with Novartis...ViiV Healthcare and the Medicines Patent Pool Sign New Voluntary Licensing Agreement to Expand Access to Innovative Long-Acting HIV Prevention Medicine
LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the Medicines Patent Pool (MPP) today announced the signing of a new voluntary licensing agreement for patents relating to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP) to help enable access in least developed, low-income, lower middle-income and Sub-Saharan African countries1,2. Through this agreement, selected generic manufactPfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries
NEW YORK & GENEVA--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working to increase access to life-saving medicines for low- and middle-income countries, today announced the signing of a voluntary license agreement for Pfizer’s COVID-19 oral antiviral treatment candidate PF-07321332, which is administered in combination with low dose ritonavir (PF-07321332; ritonavir). The agreement will enable MPP to facilitateThe Medicines Patent Pool (MPP) and Merck Enter Into License Agreement for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, to Increase Broad Access in Low- and Middle-Income Countries
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--The Medicines Patent Pool (MPP) and Merck Enter Into License Agreement for Molnupiravir to Increase Broad Access in Low- and Middle-Income Countries
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Medicines Patent Pool
Sign Up For FreeTo access detailed company insights
The Medicines Patent Pool (MPP) is a UN-backed international public health organization focused on increasing access to essential medicines and health technologies in low- and middle-income countries. MPP collaborates with partners to license these medicines and technologies, promoting the development of new formulations and expanding generic manuf... Read More
